CYC cyclopharm limited

News: CYC Cyclopharm expects FY16 underlying EBITDA of about $3.4 mln

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 6 (Reuters) - Cyclopharm Ltd (CYC)

    • Confirms it remains on track to record initial sales of ultralutetm in first half of 2017
    • Expects to report record sales revenue for 2016 full year of $14.4 million and underlying EBITDA of approximately $3.4 million
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
77.0¢
Change
-0.070(8.33%)
Mkt cap ! $85.57M
Open High Low Value Volume
84.0¢ 84.0¢ 75.5¢ $160.3K 200.1K

Buyers (Bids)

No. Vol. Price($)
1 2999 77.0¢
 

Sellers (Offers)

Price($) Vol. No.
79.5¢ 5000 1
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.